|
Company Snapshot
| COMPANY INFORMATION |
| NUCRYST Pharmaceuticals Corp. |
|
|
101 College Rd E
Princeton, NJ,
United States
08540
Tel:
(609)
228-8220
Fax:
(609)
228-8221 |
Contact Name
David B. Holtz |
Industry
|
|
|
|
|
|
|
|
| |
| FINANCIAL RATIOS AS OF FEB 4/10 |
| Listed |
Close |
52-wk
High |
52-wk
Low |
IAD |
Latest
Dividend |
Yield |
60-mo
Beta |
TSX/NCS
Nasdaq/NCST |
$1.87 |
$1.93 |
$0.19 |
n.a. |
US$0.80 |
n.a. |
n.a. |
Avg 20-day
Volume |
P/E |
12-mo
EPS |
EPS
Date |
1-yr
Return |
3-yr
Return |
5-yr
Return |
Market
Cap. (000s) |
| 1,316 |
n.a. |
US$0.01 |
Sept. 30/09 |
302.81%
|
2.81%
|
n.a. |
$34,268 |
|
| |
| ANNUAL FINANCIALS |
| Periods ended: |
12m Dec. 31/08A |
12m Dec. 31/07A |
12m Dec. 31/06A |
|
US$000s |
US$000s |
US$000s |
| Operating revenue |
20,907 |
30,092 |
24,369 |
| Net income |
(2,971) |
(4,021) |
(10,499) |
| Total assets |
41,800 |
51,299 |
45,892 |
|
US$ |
US$ |
US$ |
| Earnings per share* |
(0.16) |
(0.22) |
(0.58) |
|
% |
% |
% |
| Return on equity |
(6.98) |
(8.90) |
(36.61) |
| |
| * Common |
|
|
A Reported in accordance with U.S. GAAP |
|
| |
| TRAILING 12-MONTH VALUES |
| Periods ended: |
Sept. 30/09A |
Sept. 30/08A |
|
US$000s |
US$000s |
| Operating revenue |
20,928 |
28,721 |
| Net income |
(4) |
(944) |
|
US$ |
US$ |
| Earnings per share |
0.01 |
(0.05) |
| |
|
|
A Reported in accordance with U.S. GAAP |
|
|
COMPANY NEWS
|
Results for 'NUCRYST Pharmaceuticals Corp.' from past 30 days:
No hits.
(Links are to articles.) |
|
Printer Friendly
